Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

  1. OncologyPRO
  2. Meeting resources
  3. ESMO Targeted Anticancer Therapies Congress

Bispecifics and T-cell engagers

Live Q&A and discussion

Date

07 Mar 2022

Session

Bispecifics and T-cell engagers

Presenters

Hans van der Vliet

Authors

A. Greystoke1, H.J. van der Vliet2

Author affiliations

  • 1 The Freeman Hospital (NHS Foundation Trust) Northern Centre for Cancer Care, Newcastle-upon-Tyne/GB
  • 2 Vrije University Medical Centre (VUMC), Amsterdam/NL
More

Resources

Login to access the resources on OncologyPRO.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.